Company Overview Intra-Cellular Therapies (NASDAQ: ITCI) is a biopharmaceutical company focused on the development of therapeutics for central nervous system…
Read More »Biotech
Avidity Biosciences (NASDAQ: RNA) has seen a significant surge in its stock price, opening nearly 5% higher today. This increase…
Read More »
Immunovant, a clinical-stage biopharmaceutical company, has been making headlines with recent insider trading activities, SEC filings, and analyst opinions. This…
Read More »
Bicycle Therapeutics Plc (NASDAQ: BCYC) is making headlines with a significant pre-market surge, driven by a series of strategic moves…
Read More »
The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…
Read More »
Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…
Read More »
Updated Neuralink Is Valued at a $5 Billion Valuation. A Bet on the Future of Neural Technology Despite Uncertain Road…
Read More »